3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
14
Non-Muscle Invasive Bladder Neoplasms
10
Colorectal Neoplasms
7
Appendiceal Neoplasms
6
Anus Neoplasms
6
Peritoneal Neoplasms
5
Carcinoma, Transitional Cell
5
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ovarian Neoplasms
2
Uterine Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pleural Neoplasms
1
Peritoneal Diseases
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Necrosis
1
Nasopharyngeal Carcinoma
1
Mediastinal Neoplasms
1
Male Urogenital Diseases
1
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Mitomycin
×
1 year
×
Clear all
No trials found.